1 February 2012 – acquisition

The company has entered into an agreement to acquire 100% of the share capital of Succinct Communications Limited, a company which provides medical communications for prescription medicines.  The initial consideration comprises £2.0m in cash and the issue of 264,338 new ordinary shares in Chime, along with £0.6m in cash which represents the working capital of Succinct at acquisition that is surplus to requirements following the deal.  The shares remain a BUY.